
Methotrexate
| Product dosage: 10mg | |||
|---|---|---|---|
| Package (num) | Per pill | Price | Buy |
| 30 | $4.47 | $134.00 (0%) | π Add to cart |
| 60 | $4.02 | $268.00 $241.00 (10%) | π Add to cart |
| 90 | $3.87 | $402.00 $348.00 (13%) | π Add to cart |
| 120 | $3.79 | $536.00 $455.00 (15%) | π Add to cart |
| 180 | $3.71
Best per pill | $804.00 $668.00 (17%) | π Add to cart |
| Product dosage: 2.5mg | |||
|---|---|---|---|
| Package (num) | Per pill | Price | Buy |
| 30 | $1.93 | $58.00 (0%) | π Add to cart |
| 60 | $1.57 | $116.00 $94.00 (19%) | π Add to cart |
| 90 | $1.44 | $174.00 $130.00 (25%) | π Add to cart |
| 120 | $1.38 | $232.00 $165.00 (29%) | π Add to cart |
| 180 | $1.32 | $348.00 $237.00 (32%) | π Add to cart |
| 270 | $1.27 | $522.00 $344.00 (34%) | π Add to cart |
| 360 | $1.25
Best per pill | $696.00 $451.00 (35%) | π Add to cart |
| Product dosage: 5mg | |||
|---|---|---|---|
| Package (num) | Per pill | Price | Buy |
| 30 | $3.00 | $90.00 (0%) | π Add to cart |
| 60 | $2.77 | $180.00 $166.00 (8%) | π Add to cart |
| 90 | $2.68 | $270.00 $241.00 (11%) | π Add to cart |
| 120 | $2.64 | $360.00 $317.00 (12%) | π Add to cart |
| 180 | $2.60 | $540.00 $468.00 (13%) | π Add to cart |
| 270 | $2.57
Best per pill | $810.00 $694.00 (14%) | π Add to cart |
More info:
Advanced Diclofenac Emulgel for Targeted Pain Relief
Diclofenac Emulgel represents a significant advancement in topical analgesic therapy, combining the proven efficacy of diclofenac with innovative emulsion gel technology. This pharmaceutical formulation is specifically engineered to provide targeted relief from musculoskeletal pain and inflammation while minimizing systemic exposure. Developed through extensive clinical research, this emulgel offers healthcare professionals and patients a sophisticated alternative to oral NSAIDs, particularly for localized conditions where direct application is advantageous. Its unique carrier system ensures optimal drug penetration and bioavailability at the site of application.
Arava: Targeted Symptom Control for Rheumatoid Arthritis
Arava (leflunomide) is a disease-modifying antirheumatic drug (DMARD) specifically engineered to manage the symptoms and progression of rheumatoid arthritis. By selectively inhibiting pyrimidine synthesis in activated lymphocytes, it reduces inflammation, minimizes joint damage, and helps preserve physical function. This oral treatment offers a convenient therapeutic option for adults with moderate to severe active rheumatoid arthritis, providing sustained relief and improving quality of life. Clinical studies demonstrate its efficacy in reducing tender and swollen joint counts and slowing radiographic progression.
Arcoxia: Targeted Relief for Chronic Osteoarthritis and Pain
Arcoxia (etoricoxib) is a prescription medication belonging to the class of drugs known as selective COX-2 inhibitors, a type of nonsteroidal anti-inflammatory drug (NSAID). It is specifically engineered to provide potent anti-inflammatory and analgesic effects by selectively inhibiting the cyclooxygenase-2 (COX-2) enzyme, which is responsible for pain and inflammation, while largely sparing the COX-1 enzyme involved in protecting the stomach lining. This mechanism offers a refined approach to managing chronic musculoskeletal conditions, particularly osteoarthritis, rheumatoid arthritis, and ankylosing spondylitis, as well as acute gouty arthritis and primary dysmenorrhea.
Benemid: The Proven Uricosuric Agent for Effective Gout Management
Benemid (probenecid) is a long-established uricosuric medication specifically designed for the chronic management of hyperuricemia associated with gout and gouty arthritis. By effectively increasing the renal excretion of uric acid, it directly targets the underlying metabolic imbalance responsible for painful crystal deposition. This therapeutic action helps to reduce serum urate levels, prevent the formation of new tophi, and decrease the frequency of debilitating acute gout attacks, offering patients a path toward long-term disease control and improved quality of life.
Celebrex: Targeted Relief for Osteoarthritis and Rheumatoid Arthritis
Celebrex (celecoxib) is a prescription nonsteroidal anti-inflammatory drug (NSAID) classified as a COX-2 selective inhibitor. It is specifically engineered to provide effective anti-inflammatory and analgesic action while minimizing the gastrointestinal complications often associated with traditional NSAIDs. This medication is indicated for the management of osteoarthritis, rheumatoid arthritis, ankylosing spondylitis, and acute pain in adults. Its mechanism of action involves the selective inhibition of the cyclooxygenase-2 (COX-2) enzyme, which plays a key role in inflammation and pain mediation.
Diclofenac: Potent Pain Relief and Anti-Inflammatory Action
Diclofenac is a widely prescribed nonsteroidal anti-inflammatory drug (NSAID) renowned for its potent analgesic, anti-inflammatory, and antipyretic properties. As a cornerstone in the management of acute and chronic pain conditions, it effectively inhibits cyclooxygenase enzymes (COX-1 and COX-2), reducing the production of prostaglandins responsible for pain, swelling, and fever. Its well-established efficacy and favorable risk-benefit profile make it a first-line therapeutic option for numerous musculoskeletal and inflammatory disorders under appropriate medical supervision.
Etodolac: Targeted Relief for Chronic Pain and Inflammation
Etodolac is a prescription nonsteroidal anti-inflammatory drug (NSAID) belonging to the pyranocarboxylic acid class. It is specifically formulated to provide effective management of pain and inflammation associated with osteoarthritis and rheumatoid arthritis. By selectively inhibiting cyclooxygenase-2 (COX-2) more than cyclooxygenase-1 (COX-1), etodolac offers a favorable balance of anti-inflammatory efficacy and gastrointestinal tolerability. It is available in both immediate-release and extended-release formulations, allowing for tailored therapeutic regimens based on individual patient needs and severity of symptoms.
Feldene: Advanced Relief for Osteoarthritis and Rheumatoid Arthritis
Feldene (piroxicam) is a nonsteroidal anti-inflammatory drug (NSAID) specifically formulated to provide long-lasting relief from pain, inflammation, and stiffness associated with chronic inflammatory conditions. As a potent oxicam derivative, it offers a prolonged half-life, allowing for once-daily dosing that supports consistent therapeutic levels and improved patient compliance. Its mechanism of action involves the inhibition of cyclooxygenase (COX) enzymes, thereby reducing prostaglandin synthesis and mitigating the underlying inflammatory processes. Clinically, it is indicated for the management of osteoarthritis and rheumatoid arthritis, providing both symptomatic relief and functional improvement.
Imusporin: Advanced Immunomodulation for Chronic Inflammatory Conditions
Imusporin represents a significant advancement in the management of chronic autoimmune and inflammatory disorders, offering targeted immunomodulation with a well-characterized safety profile. Developed through rigorous clinical research, this biologic therapy selectively inhibits key inflammatory pathways while preserving essential immune function. Its novel mechanism of action provides clinicians with a powerful tool for patients with moderate-to-severe disease activity who have demonstrated inadequate response to conventional therapies. The medication’s optimized pharmacokinetic profile ensures consistent therapeutic levels with convenient dosing intervals, supporting long-term treatment adherence and disease control.